Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Gracell Biotechnologies Inc ADR (NQ: GRCL )

2.740 +0.150 (+5.79%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,805,802
Open 2.700
Bid (Size) 2.620 (3)
Ask (Size) 2.890 (2)
Prev. Close 2.590
Today's Range 2.330 - 2.890
52wk Range 1.400 - 6.990
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Week In Review: Adlai Nortye Stages $97.5 Million US IPO On Nasdaq
While ANL's IPO dropped more than 25% on its first day, netting just under $60M, private placement made up the difference. Plus: Deals, financings, trials and approvals. 
Via Talk Markets
Topics Initial Public Offering
Exposures Securities Market
Gracell Biotechnologies Reports Updated Clinical Data for FasTCAR-T GC012F for High-Risk, Newly Diagnosed Multiple Myeloma, Demonstrating 100% Stringent Complete Response Rate
From Gracell Biotechnologies Inc.
Via GlobeNewswire

Performance

YTD
+26.85%
+26.85%
1 Month
-14.64%
-14.64%
3 Month
-28.55%
-28.55%
6 Month
+44.97%
+44.97%
1 Year
-16.21%
-16.21%

More News

Read More
Gracell Biotechnologies Doses First Patient in Phase 1b/2 Clinical Trial in U.S. Evaluating GC012F for Treatment of Relapsed/Refractory Multiple Myeloma
From Gracell Biotechnologies Inc.
Via GlobeNewswire
4 Analysts Have This to Say About Gracell Biotechnologies
Via Benzinga
Preview: Gracell Biotechnologies's Earnings
Via Benzinga
Gracell Biotechnologies’ CEO Dr. William Cao Named to Prestigious PharmaVoice 100, Honoring Most Inspiring Life Science Leaders
From Gracell Biotechnologies Inc.
Via GlobeNewswire
Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences
From Gracell Biotechnologies Inc.
Via GlobeNewswire
Gracell Biotechnologies to Participate in Two Upcoming Investor Conferences
From Gracell Biotechnologies Inc.
Via GlobeNewswire
Gracell Biotechnologies Reports Second Quarter 2023 Unaudited Financial Results and Provides Corporate Update
From Gracell Biotechnologies Inc.
Via GlobeNewswire
Week In Review: BeiGene And Bristol-Myers Squibb Close BeiGene-Celgene PD-1 Partnership
Via Talk Markets
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Why Shares of Gracell Biotechnologies Are Rising Monday
Via The Motley Fool
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Gracell Biotechnologies to Report Second Quarter 2023 Financials on Monday, August 14, 2023
From Gracell Biotechnologies Inc.
Via GlobeNewswire
Gracell Biotechnologies to Participate in BTIG Virtual Biotechnology Conference
From Gracell Biotechnologies Inc.
Via GlobeNewswire
Gracell Biotechnologies Inc. (NASDAQ: GRCL) Near the Top of Equities by Percentage Gain on 7/28
Via Investor Brand Network
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Avantor Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why Li Auto Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why ToughBuilt Industries Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Surgalign Holdings Shares Are Trading Lower By Around 75%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
US Stocks Mixed; Housing Starts Surge In May
Via Benzinga
Gracell Biotechnologies to Participate in Truist Securities Cell Therapy Symposium
From Gracell Biotechnologies Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.